Grail (United States)

Recent papers from Grail (United States)

1. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyThe Lancet · 2023
2. Factors That Influence Genetic Counselors' Professional Identity—A Qualitative StudyJournal of Genetic Counseling · 2026
3. NHS-Galleri: Primary results from a randomised controlled trial to assess the clinical utility of a multi-cancer early detection (MCED) test in population screening.Journal of Clinical Oncology · 2026
4. Safety and performance results from PATHFINDER 2, a registrational study of a multi-cancer early detection (MCED) test in an intended-use population.Journal of Clinical Oncology · 2026
5. From concept to clinic: Implementation and early outcomes of MCED screening at RUSH Health System.Journal of Clinical Oncology · 2026
6. Evaluation of circulating tumor DNA (ctDNA) following liver resection in a high-risk population with colorectal liver metastases.Journal of Clinical Oncology · 2026
7. Implementation of a multi-cancer early detection (MCED) test in a private practice: Adoption, performance, and repeat-testing patterns.Journal of Clinical Oncology · 2026
8. Natural history of NGLY1 deficiency: motor function & clinical featuresHuman Molecular Genetics · 2026
9. Modeled sojourn time and sensitivity for detecting preclinical cancers retrospectively by a multi-cancer early detection testCancer Epidemiology Biomarkers & Prevention · 2026
10. Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared to Whole Body Imaging ApproachesCancer Prevention Research · 2026
11. Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkersCancer · 2026
12. Preclinical circulating tumor DNA shedding duration and prognostic implications of modeling 3669 patients with cancer in the American Cancer Society Cancer Prevention Study‐3 and Circulating Cell‐Free Genome Atlas Substudy 3Cancer · 2026
13. How genetic counselors in North America describe their professional identityJournal of Genetic Counseling · 2026
14. Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisJCO Precision Oncology · 2026
15. Prevalence of BRCA1 Promoter Methylation in Cohorts of Individuals With and Without Cancer Assessed by Circulating Cell-Free DNAJCO Precision Oncology · 2026
16. Circulating tumor DNA analysis from the prospective pT0 study of systematic endoscopic evaluation in patients undergoing radical cystectomy for bladder cancer.Journal of Clinical Oncology · 2026
17. Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus RecommendationJCO Precision Oncology · 2026
18. Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and ManagementPharmacoEconomics - Open · 2025
19. Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialClinical Cancer Research · 2025
20. Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialClinical Cancer Research · 2025